| Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
|---|
| 05/21/2003 | EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 05/15/2003 | US20030092690 Administering by inhalation |
| 05/14/2003 | EP0937100B1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof |
| 05/02/2003 | EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 05/02/2003 | EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 05/01/2003 | WO2003035668A2 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/29/2003 | US6555699 16-ENE-vitamin D derivatives |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/17/2003 | US20030073675 Novel 19-norsteroids substituted in position 11beta, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them |
| 04/16/2003 | EP1301526A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/10/2003 | WO2003020214A3 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 04/10/2003 | US20030069434 Antiestrogenic properties or tissue-selective estrogenic properties |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/08/2003 | CA2084431C 17-spirofuran-3'-ylidene steroids |
| 04/03/2003 | US20030064971 Fusidic acid derivatives |
| 03/25/2003 | US6537983 Anti-inflammatory androstane derivatives |
| 03/20/2003 | US20030055274 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/13/2003 | WO2003020214A2 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| 03/13/2003 | US20030050293 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 03/13/2003 | US20030050286 Steroids with a cyclohexene moiety are oxidized to the corresponding alpha, beta-unsaturated ketone that is converted to the corresponding vicinal diol using a hydroborating reagent followed by oxidative workup |
| 03/06/2003 | US20030045512 Androstanecarbothioic acid derivatives, especially esterified with thazol-5-ylcarboxylic acid; formulation for administration by inhalation |
| 03/05/2003 | EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 03/04/2003 | US6528676 Estrogenic compounds as anti-mitotic agents |
| 03/04/2003 | US6528631 Folates are conjugated to an oligonucleotide including at the 2'-, 3'-, 5'-, nucleobase and internucleotide linkage sites; improved transfer across cellular membranes; regioselective synthesis |
| 02/27/2003 | WO2003015792A1 Anti-tumour 2-alkoxyestradiol sulfamates |
| 02/20/2003 | WO2003013427A2 A method for preparing fluticasone derivatives |
| 02/20/2003 | WO2002072003A3 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 02/19/2003 | EP1284273A2 Estra-1,3,5(10)-trien-3-sulfamates a process for their production and pharmaceutical compositions containing them |
| 02/19/2003 | EP1283884A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 02/18/2003 | CA2351004C Formulation |
| 02/12/2003 | EP1042355B1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments |
| 02/12/2003 | EP1032584B1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 02/11/2003 | US6518262 22R-hydroxycholesta-8, 14-diene derivatives for the inhibition of meiosis |
| 01/29/2003 | CN1394141A Fulvestrant formulation |
| 01/15/2003 | EP1274718A1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group |
| 01/08/2003 | EP1273590A2 Estra- 1,3,5(10)-triene Derivatives, Methods of Preparing Such Compounds and Pharmaceutical Compositions Containing Them |
| 01/08/2003 | EP0983294B1 B-ring estratriene diol sulphates |
| 01/02/2003 | US20030004148 Regulation of meiosis |
| 01/02/2003 | EP0980383B1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 12/19/2002 | WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/19/2002 | US20020193616 16-ene-vitamin d derivatives |
| 12/19/2002 | US20020193357 Liver X receptor agonists |
| 12/18/2002 | EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 12/12/2002 | US20020187971 Hybrid cholinergic agents and compositions, methods of making, and methods of using to treat a cholinergic disorder |
| 12/11/2002 | EP1263770A1 6-oxygenated steroidal estrogens with aromatic a and b rings |
| 12/11/2002 | EP1163258B1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
| 12/10/2002 | US6492536 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 12/10/2002 | CA2084314C Starting compounds for the production of 10beta-h steroids and process for producing such starting compounds |
| 12/10/2002 | CA2084313C Process for the production of 10beta-h-steroids |
| 12/05/2002 | US20020183295 For therapy of psychotic disorders, pain, sleep disorders, depression, Alzheimer's disease, tardive dyskinesia, Picks disease, Huntington's chorea, Frederic's ataxia, Gilles de la Pteriidae's disease, Down's Syndrome |
| 12/04/2002 | EP0984980B1 20-aralkyl-5alpha-pregnane derivatives |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 11/28/2002 | WO2002094849A2 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/28/2002 | US20020177581 Novel anti-inflammatory androstane derivative |
| 11/28/2002 | CA2447780A1 Process for the production of 6, 7 - dihydroxy steroid compounds by allylic oxidation of steroid - 5 - ene compounds to steroid - 5 - ene - 7 - one compounds followed by hydroboration and oxidation and intermediates of this process |
| 11/20/2002 | EP1257531A2 Method for the preparation of carbothioic acids |
| 11/14/2002 | WO2002090375A2 Liver x receptor agonists |
| 11/12/2002 | US6479476 Treating menopausal symptoms and osteoporosis in female warm-blooded animals |
| 11/07/2002 | WO2002088167A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 11/07/2002 | WO2002070537A3 Fusidic acid derivatives |
| 11/07/2002 | CA2445839A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 10/23/2002 | EP1250138A1 Fulvestrant formulation |
| 10/16/2002 | EP1248627A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 10/09/2002 | EP0986573B1 Non-estrogenic estradiol derivatives with an antioxidant effect |
| 10/08/2002 | CA2037092C Bile acid unsaturated derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 10/03/2002 | US20020143001 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 10/02/2002 | EP0944644B1 PROCESSES FOR PREPARATION OF 3-KETO-7alpha-ALKOXYCARBONYL-delta-4,5- STEROIDS AND INTERMEDIATES USEFUL THEREIN |
| 09/19/2002 | WO2002072003A2 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | US20020133032 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
| 09/19/2002 | CA2440973A1 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/12/2002 | WO2002070537A2 Fusidic acid derivatives |
| 09/11/2002 | EP1238285A1 Steroid compounds for steroid receptor binding assays |
| 09/10/2002 | CA2132449C 17 - substituted steroids useful in cancer treatment |
| 08/29/2002 | WO2001085944A3 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 08/20/2002 | US6436917 Non-estrogenic estradiol derivative compounds with anti-oxidative activity |
| 08/15/2002 | WO2002062302A2 Steroidal derivatives |
| 08/15/2002 | CA2438221A1 Steroidal derivatives |
| 08/13/2002 | US6433200 Antitumor and antirheumatic agents, high binding afinity to vitamin d receptors and weak hypercalcemic activity |
| 08/08/2002 | US20020107233 Useful for treating hypocholesterolemia |
| 08/07/2002 | EP1039912B1 Angiostatic agents and compositions for treating glc1a glaucoma |
| 08/01/2002 | US20020103392 Corticoid-17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 08/01/2002 | US20020103391 17-methyleneandrost-4-en-3 alpha-ol for example; anxiolytic agents; ligand semiochemicals which bind to neuroepithelial receptors |
| 07/24/2002 | CN1360591A 3 alpha-hydroxy-3 beta-methoxymethyl-21-heterocycle substd. steroids with anesthetic activity |
| 07/17/2002 | EP1223174A2 Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein |
| 07/03/2002 | EP1219631A1 Antiandrogen agents |
| 06/19/2002 | EP0941054B1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 06/18/2002 | US6406718 Crystal form of steroid |
| 06/13/2002 | US20020072624 As antiestrogenic and anti-proliferative agent |
| 06/12/2002 | EP0639269B1 Ionic reservoir at electrode surface |
| 06/06/2002 | WO2001052856A3 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 06/06/2002 | US20020068834 Reacting unsaturated alkyl ketone with chiral oxazaborolidine compound to form unsaturated alkyl alcohol; intermediates for production of squalamine |
| 05/30/2002 | US20020065258 Esteradiol derivatives at the position of 1 and 17 in gonane ring containing a group selected from hydroxy, ester, ether or sulfamate |
| 05/16/2002 | WO2001062722A3 Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods |
| 05/02/2002 | WO2001074840A3 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregna 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 04/25/2002 | WO2002032922A1 Process and intermediates for the production of 7-substituted antiestrogens |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |